Tafamidis
ATC N07XX08 · 11 markets · 31 records
AU 6 records · 2 shown of 2
- 61 mgcapsuleCIPLA TAFAMIDIS tafamidis 61 mg soft capsule blister packTAFAMICIP tafamidis 61 mg soft capsule blister pack、Vyndamax、VYNDAMAX tafamidis 61 mg soft gelatin capsule blister pack
- 20 mgcapsuleVYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 2 records · 2 shown of 2
GB 2 records · 2 shown of 2
CA 2 records · 2 shown of 2
ES 2 records · 2 shown of 2
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 2 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 shown of 2
- 61 mgcapsuleVYNDAQEL 20 mg, capsule molle
- 20 mgcapsuleVYNDAQEL 20 mg, capsule molle
SG 1 records · 1 shown of 1
- 61 mgcapsuleVYNDAMAX SOFT GELATIN CAPSULE 61MG
CN 1 records · 1 shown of 1
- 61 mgcapsule维万心氯苯唑酸
TW 1 records · 1 shown of 1
- 61 mgcapsuleVyndamax soft Capsules 61 mg維萬心軟膠囊61毫克
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 61 mg capsule | Vyndamax | Vyndaqel | Vyndamax | CIPLA TAFAMIDIS tafamidis 61 mg soft capsule blister pack TAFAMICIP tafamidis 61 mg soft capsule blister pack Vyndamax+1VYNDAMAX tafamidis 61 mg soft gelatin capsule blister pack | VYNDAMAX SOFT GELATIN CAPSULE 61MG | 维万心氯苯唑酸 | Vyndaqel | Vyndamax soft Capsules 61 mg 維萬心軟膠囊61毫克 | VYNDAQEL 20 mg, capsule molle | ||
| 20 mg capsule | Vyndaqel | Vyndaqel | Vyndaqel | VYNDAQEL tafamidis meglumine 20 mg soft gelatin capsule blister pack | VYNDAQEL 20 mg, capsule molle | ||||||
| 12.2 mg capsule | Vyndaqel | ||||||||||
unknown | Vyndamax | Vyndamax Vyndaqel | TAFAMIDIS ACCORD Vyndaqel |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in ES and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en ES que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 ES 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 ES 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.